2023 Oncology Symposium

Exhibitors

Adaptive

Www.clonoSEQ.com

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries, and its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.

Bristol Myers Squibb

Daiichi Sankyo, Inc.

At Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting-edge science and technology with a genuine interest in people, we develop high-quality, life-changing solutions for the patients of today and tomorrow. We rely on reason, ingenuity, perseverance, and empathy to make bold strides in oncology. We commit to a culture of equity and belonging that fuels exceptional value for our patients and business and unlocks the power of our people. It is the sum of our diverse perspectives, experiences and skills that informs our collective capability. Our success comes from experts in collaboration: our people, scientists, health care providers, advocates – and patients themselves. Building on a 120-year heritage and a culture of innovation, we’re forging better futures through medicine for people everywhere. Together, we are creating new standards of care—our contribution to the enrichment of quality of life around the world.

Elekta

At Elekta, we have a united PURPOSE that motivates us as a company and as individuals—Hope for everyone dealing with cancer. It drives us towards our VISION – A world where everyone has access to the best cancer care. And we plan to get there through our MISSION – We improve patient lives by working together with our customers and partners. As a leading innovator of precision radiation therapy solutions, Elekta is committed to ensuring that every patient has access to the best cancer care possible. Our offering allows clinicians to treat more patients with increased quality, both with value-creating innovations in solutions and AI-supported service based on a global network.

Ethicon NeuWave

At Ethicon, a Johnson & Johnson MedTech company, putting humanity at the core of care is our passion and our purpose In collaboration with clinicians and healthcare experts around the world, we develop innovative surgical technologies and solutions to help address some of the most pressing health challenges of our time, such as metabolic disease, cardiovascular disease and cancer.

Exact Sciences

A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype tests, Exact Sciences is investing in its product pipeline to support patients before and throughout their cancer diagnosis and treatment. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.

Genentech

COMPANY INFORMATION
For more than 45 years, we've been following the science, seeking solutions to unmet medical needs. As a proud member of the Roche Group, we make medicines to treat patients with serious medical conditions.

We are headquartered in South San Francisco, California.

GENENTECH BY THE NUMBERS
785K
Square feet devoted to research
13.5K
Employees Working to Solve Unmet Medical Needs
40+
Medicines on the market
20K+
Patents Received
39
FDA Breakthrough Therapy Designations

Inari Medical

Extracting Large Clot from Large Vessels without the Need for Thrombolytics or ICU Stay.

Venous Clot is Different and Requires a Different Solution.

A Venous Solution
Instead of “re-purposing” arterial devices, Inari Medical is pioneering venous-specific devices with venous anatomy and clot morphology in mind.

Focusing on the critical vessels of venous disease, Inari has designed tools to treat both Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT).

We believe that removing clot matters, and that it should be done safely. The FlowTriever and ClotTriever were designed as non-thombolytic solutions to venous thromboembolism with that belief in mind.

Both devices are FDA 510(k) cleared for the removal of emboli and thrombi from the peripheral vasculature.

In addition, the FlowTriever System was the first mechanical thrombectomy device to be awarded an FDA indication for treatment of Pulmonary Embolism.

Janssen Biotech

We at Janssen are entrusted with one of the most important jobs in the world. We aspire to transform lives by bringing life-saving and life-changing solutions to people who need them. We’re committed to providing safe and effective medicines as well as the services and support that contribute to healthy outcomes. This calls for the best science, the most creative minds and an openness to collaborate with researchers, governments and patient organizations at every stage – from early discovery to market access and patient education.

As a leading pharmaceutical company in the United States, we focus our innovation on some of the most devastating diseases and the most complex medical challenges of our time, across six therapeutic areas:

Cardiovascular & Metabolism
Immunology
Infectious Diseases & Vaccines
Neuroscience
Oncology
Pulmonary Hypertension

https://www.janssen.com/us/

Kite Pharma

Founded in 2009 as a pioneer in cell therapy research, Kite’s leadership position in the immuno-oncology space was solidified with our research and development agreement with the National Cancer Institute in 2012 and when our commercial manufacturing site opened in El Segundo in 2016. Since our acquisition by biopharma leader Gilead Sciences in October 2017, our combined strength has accelerated the advancement of our pipeline, including the launch of YESCARTA® (axicabtagene ciloleucel) and TECARTUS® (brexucabtagene autoleucel), and has expanded the impact of our strategic partnerships.

As an independent operating company since 2019, we prioritize innovative R&D with the full resources, capabilities, and trust of Gilead. As a vital part of Gilead — a founding member of the Foundation for the NIH’s Partnership for Accelerating Cancer Therapies — we are devoted to advancing the understanding of cell therapy as a transformational treatment option for cancer. The combined strength of Kite and Gilead allows us to remain innovative, agile, and ambitious in our mission to keep improving the lives of people with all types of cancer.

https://www.kitepharma.com/

Lilly

Merck

Our purpose: We use the power of leading-edge science to save and improve lives around the world
For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world — and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.

http://www.Merckvaccines.com

Philips ECG Solutions

Philips is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care.

https://www.philips.com/ECGSolutions

Regeneron

Regeneron is a leading science-based biopharmaceutical company that invents, develops and commercializes medicines to treat serious medical conditions.